Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease
Objectives The objectives are to evaluate variation in systemic disease activity (European Alliance of Associations For Rheumatology (EULAR) Sjögren’s Syndrome Disease Activity Index (ESSDAI)) over time at group and individual patient level and to assess associations of ESSDAI low disease activity (...
Saved in:
Main Authors: | Suzanne Arends, Arjan Vissink, Hendrika Bootsma, Liseth de Wolff, Gwenny Verstappen, Alja Stel, Greetje van Zuiden, Jolien van Nimwegen, Frans Kroese |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/11/1/e004753.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of novel autoantibodies in Sjögren’s disease
by: Fiona Engelke, et al.
Published: (2025-02-01) -
Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients
by: Rick Wilbrink, et al.
Published: (2025-06-01) -
Sjögren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis
by: Koichiro Takahashi, et al.
Published: (2018-01-01) -
Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
by: Erina N. Foster, et al.
Published: (2005-01-01) -
Sjogren’s Syndrome and TAM Receptors: A Possible Contribution to Disease Onset
by: Richard Witas, et al.
Published: (2019-01-01)